Abstract
Determining practice parameters for interventional procedures is challenging due to many factors including unreliable laboratory tests to measure bleeding risk, variable usage of standardized terminology for adverse events, poorly defined standards for administration of blood products, and the growing numbers of anticoagulant and antiplatelet medications. We aim to address these and other issues faced by radiologists performing invasive procedures through a review of available literature, and experiential guidance from three academic medical centers. We discuss the significant limitations with respect to using prothrombin-time and international normalized ratio to measure bleeding risk, especially in patients with synthetic defects due to liver function. Factors affecting platelet function including the impact of uremia; recent advances in laboratory testing, including platelet function testing; and thromboelastography are also discussed. A review of the existing literature of fresh-frozen plasma replacement therapy is included. The literature regarding comorbidities affecting coagulation including malignancy, liver failure, and uremia are also reviewed. Finally, the authors present a set of recommendations for laboratory thresholds, corrective transfusions, as well as withholding and restarting medications.
Similar content being viewed by others
References
Atwell TD, Spanbauer JC, McMenomy BP, et al. (2015) The timing and presentation of major hemorrhage after 18,947 image-guided percutaneous biopsies. Am J Roentgenol 205:190–195. doi:10.2214/AJR.14.13002
Ault MJ, Rosen BT, Scher J, et al. (2015) Thoracentesis outcomes: a 12-year experience. Thorax 70:127–132. doi:10.1136/thoraxjnl-2014-206114
Corapi KM, Chen JLT, Balk EM, Gordon CE (2012) Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis 60:62–73. doi:10.1053/j.ajkd.2012.02.330
Atwell TD, Smith RL, Hesley GK, et al. (2010) Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. Am J Roentgenol 194:784–789. doi:10.2214/AJR.08.2122
Caldwell S, Northup PG (2010) Bleeding complication with liver biopsy: is it predictable? Clin Gastroenterol Hepatol 8:826–829. doi:10.1016/j.cgh.2010.06.010
McVay PA, Toy PTCY (1991) Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 31:164–171. doi:10.1046/j.1537-2995.1991.31291142949.x
McVay PA, Toy PT (1990) Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 94:747–753
O’Connor SD, Taylor AJ, Williams EC, Winter TC (2009) Coagulation concepts update. Am J Roentgenol 193:1656–1664. doi:10.2214/AJR.08.2191
Patel IJ, Davidson JC, Nikolic B, et al. (2012) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23:727–736. doi:10.1016/j.jvir.2012.02.012
Rockey DC, Caldwell SH, Goodman ZD, et al. (2009) Liver biopsy. Hepatology 49:1017–1044. doi:10.1002/hep.22742
National Cancer Institute (2009) Common terminology criteria for adverse events (CTCAE). http://evs.nci.nih.gov/ftp1/CTCAE/About.html. Accessed 12 Jan 2016
Quick AJ (1961) Clinical interpretation of the one-stage prothrombin time. Circulation 24:1422–1428
Burns ER, Goldberg SN, Wenz B (1993) Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time. Am J Clin Pathol 100:94–98
Northup PG, Caldwell SH (2013) Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol 11:1064–1074. doi:10.1016/j.cgh.2013.02.026
McGill DB, Rakela J, Zinsmeister AR, Ott BJ (1990) A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 99:1396–1400
Seeff LB, Everson GT, Morgan TR, et al. (2010) Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C Trial. Clin Gastroenterol Hepatol 8:877–883. doi:10.1016/j.cgh.2010.03.025
Short SS, Papillon S, Hunter CJ, et al. (2013) Percutaneous liver biopsy: pathologic diagnosis and complications in children. J Pediatr Gastroenterol Nutr 57:644–648. doi:10.1097/MPG.0b013e3182a0e0d8
Terjung B, Lemnitzer I, Dumoulin FL, et al. (2003) Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 67:138–145. doi:10.1159/000071293
Westheim BH, Østensen AB, Aagenæs I, et al. (2012) Evaluation of risk factors for bleeding after liver biopsy in children. J Pediatr Gastroenterol Nutr 55:82–87. doi:10.1097/MPG.0b013e318249c12a
Mueller M, Kratzer W, Oeztuerk S, et al. (2012) Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years. BMC Gastroenterol 12:173. doi:10.1186/1471-230X-12-173
Caturelli E, Squillante MM, Andriulli A, et al. (1993) Fine-needle liver biopsy in patients with severely impaired coagulation. Liver 13:270–273
Sandrasegaran K, Thayalan N, Thavanesan R, et al. (2016) Risk factors for bleeding after liver biopsy. Abdom Radiol. doi:10.1007/s00261-016-0655-5
Hollestelle MJ, Geertzen HGM, Straatsburg IH, et al. (2003) Factor VIII expression in liver disease. Thromb Haemost. doi:10.1160/TH03-05-0310
Harmsze AM, van Werkum JW, Hackeng CM, et al. (2012) The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting. Pharmacogenet Genomics 22:169–175. doi:10.1097/FPC.0b013e32834ff6e3
Levi M, Hunt BJ (2015) A critical appraisal of point-of-care coagulation testing in critically ill patients. J Thromb Haemost 13:1960–1967. doi:10.1111/jth.13126
Abdelfattah K, Cripps MW (2015) Thromboelastography and rotational thromboelastometry use in trauma. Int J Surg. doi:10.1016/j.ijsu.2015.09.036
Kang YG, Martin DJ, Marquez J, et al. (1985) Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 64:888–896
Lacey JV, Penner JA (1977) Management of idiopathic thrombocytopenic purpura in the adult. Semin Thromb Hemost 3:160–174
Kaufman RM, Djulbegovic B, Gernsheimer T, et al. (2015) Platelet transfusion: a Clinical Practice Guideline From the AABBPlatelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 162:205–213. doi:10.7326/M14-1589
Kumar A, Mhaskar R, Grossman BJ, et al. (2015) Platelet transfusion: a systematic review of the clinical evidence. Transfusion 55:1116–1127. doi:10.1111/trf.12943
Spector I, Corn M, Ticktin HE (1966) Effect of plasma transfusions on the prothrombin time and clotting factors in liver disease. N Engl J Med 275:1032–1037. doi:10.1056/NEJM196611102751902
Youssef WI, Salazar F, Dasarathy S, et al. (2003) Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol 98:1391–1394. doi:10.1016/S0002-9270(03)00241-7
Abdel-Wahab OI, Healy B, Dzik WH (2006) Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 46:1279–1285. doi:10.1111/j.1537-2995.2006.00891.x
Stanworth SJ, Walsh TS, Prescott RJ, et al. (2011) A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 15:R108. doi:10.1186/cc10129
Holland LL, Brooks JP (2006) Toward rational fresh frozen plasma transfusion the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 126:133–139. doi:10.1309/NQXHUG7HND78LFFK
Sohal AS, Gangji AS, Crowther MA, Treleaven D (2006) Uremic bleeding: pathophysiology and clinical risk factors. Thromb Res 118:417–422. doi:10.1016/j.thromres.2005.03.032
Linthorst GE, Avis HJ, Levi M (2010) Uremic thrombocytopathy is not about urea. JASN 21:753–755. doi:10.1681/ASN.2009111181
Lee HK, Kim YJ, Jeong JU, et al. (2010) Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clin Pract 114:c248–c252. doi:10.1159/000276576
Manno C, Bonifati C, Torres DD, et al. (2011) Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial. Am J Kidney Dis 57:850–855. doi:10.1053/j.ajkd.2010.12.019
Lisman T, Porte RJ (2010) Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 116:878–885. doi:10.1182/blood-2010-02-261891
Aggarwal A, Puri K, Liangpunsakul S (2014) Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review. World J Gastroenterol 20:5737–5745. doi:10.3748/wjg.v20.i19.5737
Jaffe TA, Raiff D, Ho LM, Kim CY (2015) Management of anticoagulant and antiplatelet medications in adults undergoing percutaneous interventions. AJR Am J Roentgenol 205:421–428. doi:10.2214/AJR.14.13342
Llinas RH (2006) Could discontinuation of aspirin therapy be a trigger for stroke? Nat Clin Pract Neurol 2:300–301. doi:10.1038/ncpneuro0196
Rodríguez LAG, Cea-Soriano L, Martín-Merino E, Johansson S (2011) Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ 343:d4094
van Werkum JW, Heestermans AA, Zomer AC, et al. (2009) Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 53:1399–1409. doi:10.1016/j.jacc.2008.12.055
Mehran R, Baber U, Steg PG, et al. (2013) Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 382:1714–1722. doi:10.1016/S0140-6736(13)61720-1
Benahmed A, Kianda M, Ghisdal L, et al. (2014) Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case–control study. Nephrol Dial Transplant 29:463–466. doi:10.1093/ndt/gft385
Trindade AJ, Hirten R, Slattery E, et al. (2015) Endoscopic ultrasound-guided fine-needle aspiration of solid lesions on clopidogrel may not be a high-risk procedure for bleeding: a case series. Dig Endosc . doi:10.1111/den.12565
Abu-Yousef MM, Larson JH, Kuehn DM, et al. (2011) Safety of ultrasound-guided fine needle aspiration biopsy of neck lesions in patients taking antithrombotic/anticoagulant medications. Ultrasound Q 27:157–159. doi:10.1097/RUQ.0b013e31822b5681
Melotti MK, Berg WA (2000) Core needle breast biopsy in patients undergoing anticoagulation therapy. Am J Roentgenol 174:245–249. doi:10.2214/ajr.174.1.1740245
Somerville P, Seifert PJ, Destounis SV, et al. (2008) Anticoagulation and bleeding risk after core needle biopsy. Am J Roentgenol 191:1194–1197. doi:10.2214/AJR.07.3537
Raheem OA, Casey RG, Galvin DJ, et al. (2012) Discontinuation of anticoagulant or antiplatelet therapy for transrectal ultrasound-guided prostate biopsies: a single-center experience. Korean J Urol 53:234–239. doi:10.4111/kju.2012.53.4.234
Whitson MJ, Dikman AE, von Althann C, et al. (2011) Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel? a prospective, randomized study involving 630 biopsies. J Clin Gastroenterol 45:228–233. doi:10.1097/MCG.0b013e3181eb5efd
Ortel TL (2012) Perioperative management of patients on chronic antithrombotic therapy. Blood 120:4699–4705. doi:10.1182/blood-2012-05-423228
Douketis JD, Spyropoulos AC, Spencer FA, et al. (2012) Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e326S–e350S. doi:10.1378/chest.11-2298
Ellis G, John Camm A, Datta SN (2015) Novel anticoagulants and antiplatelet agents; a guide for the urologist. BJU Int 116:687–696. doi:10.1111/bju.13131
Oprea AD, Popescu WM (2013) Perioperative management of antiplatelet therapy. Br J Anaesth 111:i3–i17. doi:10.1093/bja/aet402
Thomas M, Shen KR (2015) Coagulopathy and anticoagulation during thoracic surgery. Thorac Surg Clin 25:309–323. doi:10.1016/j.thorsurg.2015.04.005
van Veen JJ, Makris M (2015) Management of peri-operative anti-thrombotic therapy. Anaesthesia 70:58-e23. doi:10.1111/anae.12900
Williams LA III, Hunter JM Jr, Marques MB, Vetter TR (2014) Periprocedural management of patients on anticoagulants. Clin Lab Med 34:595–611. doi:10.1016/j.cll.2014.06.010
Schafer AI (1999) Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med 106:25S–36S
Schafer AI (1995) Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 35:209–219. doi:10.1002/j.1552-4604.1995.tb04050.x
Lewis SR, Nicholson A, Cardwell ME, et al. (2013) Nonsteroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy. Cochrane Database of Syst Rev 7:CD003591
Riggin L, Ramakrishna J, Sommer DD, Koren G (2013) A 2013 updated systematic review & meta-analysis of 36 randomized controlled trials; no apparent effects of non steroidal anti-inflammatory agents on the risk of bleeding after tonsillectomy. Clin Otolaryngol 38:115–129. doi:10.1111/coa.12106
Meek IL, Vonkeman HE, Kasemier J, et al. (2012) Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study. Eur J Clin Pharmacol 69:365–371. doi:10.1007/s00228-012-1370-y
Sarwar A, Boland G, Monks A, Kruskal JB (2015) Metrics for radiologists in the era of value-based health care delivery. RadioGraphics 35:866–876. doi:10.1148/rg.2015140221
American College of Radiology (2015) CT Accreditation Program Requirements.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
All authors declare that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants performed by any of the authors.
Rights and permissions
About this article
Cite this article
Kohli, M., Mayo-Smith, W., Zagoria, R. et al. Image-guided intervention in the coagulopathic patient. Abdom Radiol 41, 667–676 (2016). https://doi.org/10.1007/s00261-016-0663-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-016-0663-5